NCT03400878View on ClinicalTrials.gov

Comparing Morbidity and Mortality Effects of Two Different Strains of BCG

PHASE4CompletedINTERVENTIONAL
Enrollment

17,505

Participants

Timeline

Start Date

October 14, 2017

Primary Completion Date

June 1, 2020

Study Completion Date

October 1, 2020

Conditions
Heterologous ImmunityInfant MorbidityInfant MortalityTrained ImmunityVaccine ReactionVaccine Adverse Reaction
Interventions
BIOLOGICAL

BCG-Japan

One dose of 0.05 ml BCG-Japan vaccine applied to the left deltoid region.

BIOLOGICAL

BCG-Russia

One dose of 0.05 ml BCG-Russia vaccine applied to the left deltoid region.

Trial Locations (2)

Unknown

Bandim Health Project, Apartado 861, Bissau

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

Research Center for Vitamins and Vaccines

UNKNOWN

lead

Bandim Health Project

OTHER

NCT03400878 - Comparing Morbidity and Mortality Effects of Two Different Strains of BCG | Biotech Hunter | Biotech Hunter